Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.
3 in 4 Patients Don’t Trust AI in Healthcare Setting
What You Should Know: Carta Healthcare®, a company whose mission is to improve patient care by harnessing the value of clinical data, today announced the results